Author:
Marco-Benedí Victoria,Cenarro Ana,Laclaustra Martín,Calmarza Pilar,Bea Ana M.,Vila Àlex,Morillas-Ariño Carlos,Puzo José,Mediavilla Garcia Juan Diego,Fernández Alamán Amalia Inmaculada,Suárez Tembra Manuel,Civeira Fernando
Funder
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
Reference32 articles.
1. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies;Tsimikas;J Am Coll Cardiol,2017
2. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association;Reyes-Soffer;Arterioscler Thromb Vasc Biol,2022
3. Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100;Sommer;Biochemistry,1991
4. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations;Boerwinkle;J Clin Invest,1992
5. The unique lipoprotein(a): properties and immunochemical measurement;Albers;Clin Chem,1990